Substituted triazole derivatives and uses thereof

US11149023B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Marie-Pierre Collin-Kroepelin · Wuppertal, DE
• Peter Kolkhof · Wuppertal, DE
• Thomas Neubauer · Wuppertal, DE
• Chantal Fuerstner · Neheim, DE
• Elisabeth Pook · Wuppertal, DE
• Matthias Beat WITTWER · Riehen, CH
• Heiko Schirmer · Solingen, DE
• Hanna Tinel · Wuppertal, DE

Key dates

• Filing date: Oct 17, 2018
• Grant date: Oct 19, 2021
• Expiry date: Oct 17, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K45/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.